OSE Immunotherapeutics Accelerates Strategic Refocusing to Advance Late Stage Value Drivers Lusvertikimab and Tedopi®

Streamlining of selected non‑strategic early-stage programs completed, consistent with previously announced three-year 2026-2028 strategic planNo ...

Matador Announces Intention to Spinout its Gold Treasury Platform, GODL Corp., into a Public Company

Matador has recently expanded its global footprint by investing in HODL Systems, one of India’s first digital asset treasury ...

Hycroft Mining Holding Corporation: Hycroft Files 2025 10-K and Provides Corporate Update

Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") announces 2025 results and filing of ...

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of treatments ...
BMJ Global Health

Leveraging community insights and navigating logistical challenges: a case study of the 2024 polio vaccination campaign in Gaza, State of Palestine

This case study describes how high vaccination coverage was achieved during the 2024 polio vaccination campaign in Gaza amid ...
Goldseiten

First Phosphate Receives Conditional Approval for up to $16.7 Million Non-Repayable Contribution from the Government of Canada

Saguenay, Québec - First Phosphate Corp. has been conditionally approved for a non-repayable contribution agreement for up to C$16.7 million with the Government of Canada through Natural Resources ...
Goldseiten

E3 Lithium Receives Conditional Approval for up to C$36.5 million in Federal Government Funding to Accelerate its Clearwater Project

E3 Lithium Ltd. , "E3", "E3 Lithium" or the "Company," a leader in Canadian lithium development, has been conditionally approved for up to C$36.5 million of non-repayable funding through the ...